Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C

Younossi ZM, Stepanova M, Henry L, Gane EJ, Jacobson IM, Lawitz EJ, et al. Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2014;12(8):1349-1359.

Publication Type:

Journal Article

Authors:

Z M Younossi; Stepanova, M.; Henry, L.; E J Gane; Ira M. Jacobson; E J Lawitz; David R. Nelson; Gerber, L.; Nader, F.; Hunt, S.

Source:

Clin Gastroenterol Hepatol, Volume 12, Issue 8, p.1349-1359 (2014)

Keywords:

Affect, analysis, Cities, clinical trial, Clinical Trials, Disease, Fatigue, Florida, Genotype, genotype 1, HCV, Health, hepatitis, Hepatitis C, hepatitis C virus, Infection, interferon, Life, Liver, Liver Diseases, Medicine, methods, New York, New Zealand, Patients, pegylated, pegylated interferon, Quality of Life, Questionnaires, Research, Ribavirin, sofosbuvir, sustained virologic response, Texas, therapy, Time, treatment, Work

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24316172

Export Citation:

RIS Format

Top